Indivior Pharmaceuticals Inc
INDVNASDAQHealthcare● Active
$37.39
$-0.23(-0.60%)
Market Cap$4.7B
P/E Ratio—
52W High$41
52W Low$13.44
Indivior Pharmaceuticals Inc（INDV）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · INDV · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.20B | $0.32B | $0.41B | $0.90B | $1.10B |
| Net Receivables | $0.26B | $0.25B | $0.25B | $0.22B | $0.20B |
| Inventory | $0.15B | $0.18B | $0.14B | $0.11B | $0.10B |
| Total Current Assets | $0.65B | $0.84B | $1.27B | $1.27B | $1.44B |
| PP&E Net | $0.17B | $0.14B | $0.12B | $0.09B | $0.10B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.01B | $0.01B | $0.07B | $0.08B |
| Total Assets | $1.20B | $1.32B | $1.76B | $1.78B | $1.83B |
| Liabilities | |||||
| Short-Term Debt | $0.04B | $0.02B | $0.01B | $0.00B | $0.00B |
| Accounts Payable | $0.05B | $0.06B | $0.04B | $0.03B | $0.03B |
| Total Current Liabilities | $0.91B | $0.94B | $1.29B | $1.02B | $0.80B |
| Long-Term Debt | $0.29B | $0.32B | $0.24B | $0.24B | $0.24B |
| Total Liabilities | $1.30B | $1.67B | $1.96B | $1.73B | $1.63B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.24B) | ($0.45B) | ($0.29B) | $1.31B | $1.44B |
| Total Stockholders Equity | ($0.10B) | ($0.35B) | ($0.19B) | $0.05B | $0.20B |
| Total Liab & Equity(computed) | $1.20B | $1.32B | $1.76B | $1.78B | $1.83B |
| Debt Summary | |||||
| Total Debt | $0.35B | $0.38B | $0.28B | $0.28B | $0.29B |
| Net Debt | $0.16B | $0.06B | ($0.03B) | ($0.50B) | ($0.82B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Indivior Pharmaceuticals Inc
关于Indivior Pharmaceuticals Inc（INDV）资产负债表
Indivior Pharmaceuticals Inc总资产$1.20B，现金及短期投资$0.20B，总负债$1.30B，总债务$0.35B，股东权益($0.10B)。
常见问题
INDV · 4 问Indivior Pharmaceuticals Inc总债务$0.35B，净债务$0.16B。
INDV total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10